Company / Revenue per Share
Intellia Therapeutics, Inc. Revenue per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$0.66
FY2025
5-year range
$0.42 / $0.70
FY2021-FY2025
Trend
+6.6%
vs FY2024
Sector context
#142 of 147
Health Care
What the data says
Among 147 Health Care companies, Intellia Therapeutics, Inc. is in the bottom 3% for revenue per share. Revenue per Share has fluctuated over the past 10 years, ranging from $0.42 in FY2023 to $1.16 in FY2020.
Based on SEC 10-K filings.
0.66 in FY2025 with a 5-year CAGR of -10.5%.
Improved from $0.42 to $0.66 over the past 2 years.
Health Care sector context is included.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- -1.8%
- 5-Year CAGR
- -10.5%
- 10-Year CAGR
- -
Sector benchmark
Bottom 3% in Health CareTop 97% of 147This company $0.66 Sector average $127.83
▼
-99.5% below sector average
Key checks
Key Insights
- In FY2025, revenue per share increased 6.6% year-over-year.
- Ranks #142 out of 147 companies in the Health Care sector.
- Peak revenue per share was recorded in FY2020.
- Lowest revenue per share in the period was in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -2.14 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.66 | +6.6% |
| FY2024 | $0.62 | +49.4% |
| FY2023 | $0.42 | -40.5% |
| FY2022 | $0.70 | +40.2% |
| FY2021 | $0.50 | -56.8% |
| FY2020 | $1.16 | +21.2% |
| FY2019 | $0.95 | +32.7% |
| FY2018 | $0.72 | -1.0% |
| FY2017 | $0.73 | -2.2% |
| FY2016 | $0.74 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026